Pharmaceutical products; requiring publishing of certain information by manufacturers. Effective date.
Second Reading referred to Business and Insurance
Email me when SB 2024 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 2024. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill forces any company that makes a pharmaceutical product, including research‑only items, to list every active, inactive, biological and synthetic component, submit the list to Oklahoma’s Board of Pharmacy, post it on a website and include it on product labeling. It also creates civil and criminal penalties for companies that fail to comply and gives consumers the right to sue. The measure is intended to increase transparency for patients and regulators.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 2024
3 free questions a day, no accountHistory
- Second Reading referred to Business and Insurance
- First Reading
- Authored by Senator Deevers
Sponsors
- Deevers · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 2024 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 2024 freeOr ask your AI assistant about SB 2024 directly:
Add to Claude, ChatGPT or Cursor